Company news

Prescient Therapeutics Limited news in 2019

Prescient Therapeutics Limited's news releases, calls and decks from 2019, newest first.

View company

PTX-200 High Overall Response in Ph2a Breast Cancer trial

December 22, 2019

Encouraging data from PTX-200 ovarian cancer trial

December 11, 2019

Third complete response in PTX-200 AML Trial

November 26, 2019

PTX in new CAR-T collaboration

November 17, 2019

1st patient dosed in trial for first in class drug PTX-100

November 13, 2019

Receipt of R&D Tax Rebate

November 7, 2019

Prescient Ausbiotech Ras Presentation

October 30, 2019

September 2019 Appendix 4C - Quarterly

October 29, 2019

Appendix 4E and 2019 Annual Report

August 25, 2019

June 2019 Appendix 4C - Quarterly

July 23, 2019

PTX Initiates Phase 1b Clinical Trial for PTX-100

July 10, 2019

Change to Exercise Price of Options

May 30, 2019

Canadian Patent Granted for PTX-200

May 15, 2019

Entitlement Offer Results and Shortfall Notification

April 26, 2019

March 2019 Appendix 4C - Quarterly

April 24, 2019

Despatch of Entitlement Offer Documents

April 3, 2019

Prospectus

March 24, 2019

Capital Raising Presentation - March 2019

March 24, 2019

Prescient Completes Equity Raising to Raise $9.1 Million

March 24, 2019

December 2018 Appendix 4C - Quarterly

January 31, 2019

Decks in 2019